Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Lisa Malter"'
Autor:
Badr Al-Bawardy, Lisa Malter, Adam C Ehrlich, Florian Rieder, Jill K J Gaidos, Deborah Proctor, Donna M Windish
Publikováno v:
Inflammatory Bowel Diseases.
Lay SummaryIn this multicenter survey study, we found that many gastroenterology fellows lacked confidence and desired a “moderate to a lot more” training in important inflammatory bowel disease management domains.
Autor:
Dana Berg, Shannon Chang, Simon Hong, Janice Jang, Tarik H. Kirat, David Hudesman, Lisa Malter, Feza H. Remzi, Jordan E. Axelrad
Publikováno v:
Digestive Diseases and Sciences. 66:3753-3759
There is wide variation in the quality of care of hospitalized patients with inflammatory bowel disease (IBD). Prior studies have demonstrated that a specialized inpatient IBD service improves short-term outcomes. In this study, we assessed the impac
Autor:
Dolly Sharma, Si Xuan, Yuri Sanchez-Gonzalez, Jenny Griffith, Lisa Malter, Anita Afzali, David T. Rubin
Publikováno v:
American Journal of Gastroenterology. 117:e1813-e1814
Publikováno v:
American Journal of Gastroenterology. 117:e559-e560
Autor:
Alec J. Megibow, David Hudesman, Shannon Chang, Justin M. Ream, Hua Zhong, Bari Dane, Lisa Malter, Brian P. Bosworth, Yuhe Xia, Sarina C. Lowe
Publikováno v:
Abdominal Radiology. 45:2663-2668
For more than half of Crohn’s disease patients, strictures will cause bowel obstructions that require surgery within 10 years of their initial diagnosis. This study utilizes computed tomography imaging and clinical data obtained at the initial emer
Autor:
Becky Johnson Rescola, Animesh Jain, Adam S. Cheifetz, Orna G Ehrlich, Benjamin L. Cohen, Lisa Axisa, Jill Gaidos, Lisa Malter, Sudha Sarode, Lori Butterfield
Publikováno v:
Inflammatory Bowel Diseases. 26:1445-1450
Background As treatments, management strategies, and the role of advanced practice providers (APPs) have evolved in recent years, the Crohn’s & Colitis Foundation sought to understand the educational and resource needs of clinicians caring for pati
Publikováno v:
Current Gastroenterology Reports. 23
As treatment options for Inflammatory Bowel Disease (IBD) expand each class of medication will have specific safety concerns and side-effect profiles that need to be considered for optimal treatment of patients. We will review the most recent safety
Autor:
Badr Al-Bawardy, Lisa Malter, Adam C. Ehrlich, Florian Rieder, Jill K. Gaidos, Deborah Proctor, Donna Windish
Publikováno v:
American Journal of Gastroenterology. 117:e632-e632
Autor:
Benjamin L Cohen, Animesh Jain, Stefan D. Holubar, Bincy Abraham, Anita Afzali, Jill Gaidos, Florian Rieder, Adam S. Cheifetz, Christian D. Stone, Robert P. McCabe, Alan C. Moss, David Hudesman, Gaurav Syal, Mariastella Serrano, Lisa Malter
Publikováno v:
Inflamm Bowel Dis
Background With the management of inflammatory bowel disease (IBD) becoming increasingly complex, incorporating preventive care health maintenance measures can be challenging. The aim of developing these updated recommendations is to provide more spe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9df85540b632560cac21a0c69840bb7b
https://europepmc.org/articles/PMC8861367/
https://europepmc.org/articles/PMC8861367/
Autor:
Samantha Zullow, Yangtian Yi, Shannon Chang, Shintaro Akiyama, Seth Shaffer, David Hudesman, David T. Rubin, Simon Hong, Noa Krugliak Cleveland, Jordan E. Axelrad, Lisa Malter
Publikováno v:
Crohn's & Colitis 360. 3
Background Ustekinumab has been recently approved for the treatment of moderately to severely active ulcerative colitis (UC). The registry trials for ustekinumab in UC demonstrated efficacy and safety, but data on real-world outcomes are limited. We